Hemolytic anemia due to hydrochlorothiazide: A case report
PDF
Cite
Share
Request
Case Report
P: 111-113
September 2016

Hemolytic anemia due to hydrochlorothiazide: A case report

IJCVA 2016;2(3):111-113
1. Department of Cardiology, Elazig Training and Research Hospital, Elazig, Turkey
2. Department of Cardiology, Firat University School of Medicine, Elazig, Turkey
No information available.
No information available
Received Date: 06.04.2016
Accepted Date: 07.06.2016
PDF
Cite
Share
Request

ABSTRACT

Drug-associated hemolytic anemia is very rare. Hydrochlorothiazides are commonly used as diuretic or antihypertensive agents. In this report, we present an 80-year-old male patient who developed hemolytic anemia 20 days after using a combination of angiotensin receptor blocker and hydrochlorothiazide for the treatment of hypertension.

Keywords: Hemolytic anemia Hydrochlorothiazide Drug

References

2024 ©️ Galenos Publishing House